News About: Pharm. Industry
Domestic pharmaceutical firms urged to advance into Chinese pharmaceutical market in detailed...
Domestic pharmaceutical firms urged to advance into Chinese pharmaceutical market in detailed market analyses
The Korean firms effective inroads to the Chinese pharmaceutical market should require a group of market...
Vitamin C drink taking over tonic drink markets.
So called "Drink" market led by tonic drink preparations since long time has been rapidly reshuffled by the recent new market entries of vitamin C drink and wild ginseng preparations.
The tonic drink market has...
Wyeth Korea to launch Enbrel at year-end
Wyeth Korea announced the Korea Food and Drug Administration has recently approved Enbrel (entanercept), TNF (tumor necrosis factor) inhibitor for the treatment of rheumatoid arthritis drug, as local trials last March...
Chong Kun Dang to introduce novel ulcerative colitis medication from US-based Salix Pharmaceuticals
Chong Kun Dang Pharmaceuticals said it recently signed with the U.S.-based Salix Pharmaceuticals (Dr. Lorin Johnson, a co-founder of Salix), a leading pharmaceutical firm in the sales/marketing of digestive drugs, an ...
Dong-A's DA-8159 wins KIPO's patent award
Dong-A Pharm said its novel pyrazolopyrimidine derivative (DA-8159), an impotence medication, recently won Chi Seok-yong Award in the third quarter of this year from the Korean Intellectual Property Office.
DA-8159...
KPMA stresses fair trade code in scientific seminars
The Korea Pharmaceutical Manufacturers Association has recently urged pharmaceutical companies to strictly abide by a fair trade code in supporting a variety of scientific seminars at home and abroad.
Citing that p...
Sales and product development staffs in difficult situations
Because of a protracted business slow in the pharmaceutical industry the job positions of high executive members and staffs responsible for the company sales and new product development were getting squeezed.
Most ...
Crestor to start first multinational trials "DISCOVERY" in Korea
Pharmaceutical business sources say that local DISCOVERY trials for AstraZeneca's lead product Crestor for the treatment of hyperlipidemia are now underway with the initiative of a Korean chief investigator, with an a...
MSD Korea launches V65 campaign for Vioxx in Korea
MSD Korea said it has initiated a V65 campaign towards local doctors and patients from last September as part of its efforts to promote is lead product Vioxx for the treatment of arthritis, adding that its earlier "Vo...
Janssen Korea to file application for new anticancer in early next yearJanssen Korea said it would file a new application for Velcade, proteasome inhibitor in early next year in line with its launching program.
The U.S. FDA announced on May 13 t...
|
